Trade PBLS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Parabilis Medicines, Inc. (PBLS) is trading at US$38.88, down 1.06% today as of Aug 28, 12:00 EDT. The company has a market capitalisation of US$4.86B. Over the past 52 weeks, PBLS has traded between US$19.00 and US$41.49. On Syfe you can trade PBLS with $0 commission and add it to your watchlist.
| Previous close | US$39.29 |
|---|---|
| Market cap | US$4.86B |
| 52-week range | US$19.00 – US$41.49 |
| Volume | 445.43K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Parabilis Medicines, Inc.
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Year: 2026
Parabilis Medicines Closes Initial Public Offering
Jun 11, 8:36 PM · MT Newswires
Parabilis Medicines, Inc. (PBLS) stock is trading at US$38.88, -1.06% from the previous close of US$39.29.
The market cap for Parabilis Medicines, Inc. (PBLS) stock is approximately US$4.86B.
The 52-week high for Parabilis Medicines, Inc. (PBLS) stock is US$41.49.
The 52-week low for Parabilis Medicines, Inc. (PBLS) stock is US$19.00.
Parabilis Medicines, Inc. (PBLS) does not currently pay a dividend.
Stay on top of PBLS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
